ERBB2 and breast cancer: The most common BC subtype is positive for hormone receptor (HR+) and does not overexpress the human epidermal growth factor receptor 2 (HER2/neu), accounting for 68% of all BC cases (https://seer.cancer.gov/statfacts/html/breast-subtypes.html).